Cargando…
Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838245/ https://www.ncbi.nlm.nih.gov/pubmed/29507282 http://dx.doi.org/10.1038/s41398-018-0100-3 |
_version_ | 1783304219538751488 |
---|---|
author | Goldstein-Piekarski, Andrea N. Staveland, Brooke R. Ball, Tali M. Yesavage, Jerome Korgaonkar, Mayuresh S. Williams, Leanne M. |
author_facet | Goldstein-Piekarski, Andrea N. Staveland, Brooke R. Ball, Tali M. Yesavage, Jerome Korgaonkar, Mayuresh S. Williams, Leanne M. |
author_sort | Goldstein-Piekarski, Andrea N. |
collection | PubMed |
description | Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD. Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR. A whole-brain voxel-wise t-test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up. Connectivity was seeded in the PCC, an important node of the DMN. We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment. Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity. In validation analyses, we demonstrate that PCC–ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy. In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold. Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment. The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices. |
format | Online Article Text |
id | pubmed-5838245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58382452018-03-06 Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers Goldstein-Piekarski, Andrea N. Staveland, Brooke R. Ball, Tali M. Yesavage, Jerome Korgaonkar, Mayuresh S. Williams, Leanne M. Transl Psychiatry Article Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD. Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR. A whole-brain voxel-wise t-test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up. Connectivity was seeded in the PCC, an important node of the DMN. We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment. Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity. In validation analyses, we demonstrate that PCC–ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy. In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold. Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment. The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices. Nature Publishing Group UK 2018-03-06 /pmc/articles/PMC5838245/ /pubmed/29507282 http://dx.doi.org/10.1038/s41398-018-0100-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Goldstein-Piekarski, Andrea N. Staveland, Brooke R. Ball, Tali M. Yesavage, Jerome Korgaonkar, Mayuresh S. Williams, Leanne M. Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
title | Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
title_full | Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
title_fullStr | Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
title_full_unstemmed | Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
title_short | Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
title_sort | intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838245/ https://www.ncbi.nlm.nih.gov/pubmed/29507282 http://dx.doi.org/10.1038/s41398-018-0100-3 |
work_keys_str_mv | AT goldsteinpiekarskiandrean intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers AT stavelandbrooker intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers AT balltalim intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers AT yesavagejerome intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers AT korgaonkarmayureshs intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers AT williamsleannem intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers |